Literature DB >> 26256213

Rif1 Is Required for Resolution of Ultrafine DNA Bridges in Anaphase to Ensure Genomic Stability.

Rutger C C Hengeveld1, H Rudolf de Boer2, Pepijn M Schoonen2, Elisabeth G E de Vries2, Susanne M A Lens3, Marcel A T M van Vugt2.   

Abstract

Sister-chromatid disjunction in anaphase requires the resolution of DNA catenanes by topoisomerase II together with Plk1-interacting checkpoint helicase (PICH) and Bloom's helicase (BLM). We here identify Rif1 as a factor involved in the resolution of DNA catenanes that are visible as ultrafine DNA bridges (UFBs) in anaphase to which PICH and BLM localize. Rif1, which during interphase functions downstream of 53BP1 in DNA repair, is recruited to UFBs in a PICH-dependent fashion, but independently of 53BP1 or BLM. Similar to PICH and BLM, Rif1 promotes the resolution of UFBs: its depletion increases the frequency of nucleoplasmic bridges and RPA70-positive UFBs in late anaphase. Moreover, in the absence of Rif1, PICH, or BLM, more nuclear bodies with damaged DNA arise in ensuing G1 cells, when chromosome decatenation is impaired. Our data reveal a thus far unrecognized function for Rif1 in the resolution of UFBs during anaphase to protect genomic integrity.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26256213     DOI: 10.1016/j.devcel.2015.06.014

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  38 in total

Review 1.  Building bridges between chromosomes: novel insights into the abscission checkpoint.

Authors:  Eleni Petsalaki; George Zachos
Journal:  Cell Mol Life Sci       Date:  2019-07-13       Impact factor: 9.261

Review 2.  The control of DNA repair by the cell cycle.

Authors:  Nicole Hustedt; Daniel Durocher
Journal:  Nat Cell Biol       Date:  2016-12-23       Impact factor: 28.824

3.  RIF1 acts in DNA repair through phosphopeptide recognition of 53BP1.

Authors:  Dheva Setiaputra; Cristina Escribano-Díaz; Julia K Reinert; Pooja Sadana; Dali Zong; Elsa Callen; Chérine Sifri; Jan Seebacher; André Nussenzweig; Nicolas H Thomä; Daniel Durocher
Journal:  Mol Cell       Date:  2022-02-24       Impact factor: 17.970

4.  Nuclear organisation and replication timing are coupled through RIF1-PP1 interaction.

Authors:  Ilya M Flyamer; Kyle N Klein; Stefano Gnan; Eleonora Castelli; Alexander Rapp; Andreas Maiser; Naiming Chen; Patrick Weber; Elin Enervald; M Cristina Cardoso; Wendy A Bickmore; David M Gilbert; Sara C B Buonomo
Journal:  Nat Commun       Date:  2021-05-18       Impact factor: 14.919

5.  Rif1 Regulates the Fate of DNA Entanglements during Mitosis.

Authors:  Sophie Zaaijer; Nadeem Shaikh; Rishi Kumar Nageshan; Julia Promisel Cooper
Journal:  Cell Rep       Date:  2016-06-16       Impact factor: 9.423

6.  Unresolved recombination intermediates lead to ultra-fine anaphase bridges, chromosome breaks and aberrations.

Authors:  Ying Wai Chan; Kasper Fugger; Stephen C West
Journal:  Nat Cell Biol       Date:  2017-12-18       Impact factor: 28.824

Review 7.  Around and beyond 53BP1 Nuclear Bodies.

Authors:  Anne Fernandez-Vidal; Julien Vignard; Gladys Mirey
Journal:  Int J Mol Sci       Date:  2017-12-05       Impact factor: 5.923

8.  Dynamics of RIF1 SUMOylation is regulated by PIAS4 in the maintenance of Genomic Stability.

Authors:  Ramesh Kumar; Chit Fang Cheok
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

9.  Bub3-BubR1-dependent sequestration of Cdc20Fizzy at DNA breaks facilitates the correct segregation of broken chromosomes.

Authors:  Nicolas Derive; Cedric Landmann; Emilie Montembault; Marie-Charlotte Claverie; Priscillia Pierre-Elies; Damien Goutte-Gattat; Nabila Founounou; Derek McCusker; Anne Royou
Journal:  J Cell Biol       Date:  2015-11-09       Impact factor: 10.539

Review 10.  Maintaining Genome Stability in Defiance of Mitotic DNA Damage.

Authors:  Stefano Ferrari; Christian Gentili
Journal:  Front Genet       Date:  2016-07-21       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.